Ralph Stadhouders

28PUBLICATIONS
138CO-AUTHORS
Environmentally sustainable engineeringEpidemiological methodsCancer therapy (excl. chemotherapy and radiation therapy)Innate immunityEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|May 01, 2026
Foxp3: The epigenetic engineer of regulatory T cell identity.

|Mar 14, 2026
Improving Lung Cancer Screening Selection: A Comparative Analysis of Risk Models and Traditional Criteria in a Western European General Population.

Danrong Zhong, Grigory Sidorenkov, Marcel J W Greuter

|Nov 28, 2025
REACtiVe-2: phase I evaluation of dendritic cell vaccination and agonistic CD40 therapy following (m)FOLFIRINOX in metastatic pancreatic cancer.

Songul Kucukcelebi, Freek R van 't Land, Sjoerd H van der Burg

|Jul 31, 2025
Epigenetic priming as a driver of memory recall and dysfunction in T cells.

Mieke Metzemaekers, Niels J Rinzema, Ralph Stadhouders

|Jun 11, 2025
Butyrate Selectively Targets Super-Enhancers and Transcriptional Networks Associated with Human Mast Cell Function.

Jelle Folkerts, Marjolein J W de Bruijn, Wilfred F J van IJcken

|Jun 03, 2025
CTG-Initiated Cryptic Peptide Translation Up- and Downstream of a Canonical ATG Start Codon Is Enhanced by TLR Stimulation and Induces Tumor Regression in Mice.

Ziye Song, Youkyung Lim, Anneloes van Krimpen

Pageof 5

Frequent Collaborators

5 joint publications

Wilfred van Ijcken

5 joint publications

Thomas Graf

5 joint publications

Rudi W Hendriks

4 joint publications

Gert-Jan Braunstahl